Abstract:Diverse forms of resistance to anticancer drugs can lead to the failure of chemotherapy. Drug resistance is one of the most intractable issues for successfully treating cancer in current clinical practice. Effective clinical approaches that could counter drug resistance by restoring the sensitivity of tumors to the targeted agents are urgently needed. As numerous experimental results on resistance mechanisms have been obtained and a mass of high-throughput data has been accumulated, mathematical modeling and computational predictions using systematic and quantitative approaches have become increasingly important, as they can potentially provide deeper insights into resistance mechanisms, generate novel hypotheses or suggest promising treatment strategies for future testing. In this review, we first briefly summarize the current progress of experimentally revealed resistance mechanisms of targeted therapy, including genetic mechanisms, epigenetic mechanisms, posttranslational mechanisms, cellular mechanisms, microenvironmental mechanisms and pharmacokinetic mechanisms. Subsequently, we list several currently available databases and Web-based tools related to drug sensitivity and resistance. Then, we focus primarily on introducing some state-of-the-art computational methods used in drug resistance studies, including mechanism-based mathematical modeling approaches (e.g. molecular dynamics simulation, kinetic model of molecular networks, ordinary differential equation model of cellular dynamics, stochastic model, partial differential equation model, agent-based model, pharmacokinetic-pharmacodynamic model, etc.) and data-driven prediction methods (e.g. omics data-based conventional screening approach for node biomarkers, static network approach for edge biomarkers and module biomarkers, dynamic network approach for dynamic network biomarkers and dynamic module network biomarkers, etc.). Finally, we discuss several further questions and future directions for the use of computational methods for studying drug resistance, including inferring drug-induced signaling networks, multiscale modeling, drug combinations and precision medicine.

Computer Prediction of Drug Resistance Mutations in Proteins

Predicting Anticancer Drug Resistance Mediated by Mutations

Mathematical modeling and computational prediction of cancer drug resistance

Bioinformatics toolbox for exploring target mutation-induced drug resistance

Prediction of HIV Drug Resistance by Combining Sequence and Structural Properties

Progress on the development of prediction tools for detecting disease causing mutations in proteins

AIMMS suite: a web server dedicated for prediction of drug resistance on protein mutation.

A Combined Computational and Experimental Strategy Identifies Mutations Conferring Resistance to Drugs Targeting the BCR-ABL Fusion Protein

Detecting and Understanding Combinatorial Mutation Patterns Responsible for HIV Drug Resistance

Bioinformatics Research on Drug Sensitivity Prediction

Prediction of druggable proteins using machine learning and functional enrichment analysis: a focus on cancer-related proteins and RNA-binding proteins

Predicting Drug Resistance of the HIV‐1 Protease Using Molecular Interaction Energy Components

SPLDExtraTrees: robust machine learning approach for predicting kinase inhibitor resistance

A mutation-induced drug resistance database (MdrDB)

Proteogenomic studies on cancer drug resistance: towards biomarker discovery and target identification

Systematic prediction of drug resistance caused by transporter genes in cancer cells

Application of Computational Methods in Understanding Mutations in Mycobacterium tuberculosis Drug Resistance

Revealing the Mutation Patterns of Drug-Resistant Reverse Transcriptase Variants of Human Immunodeficiency Virus through Proteochemometric Modeling

Systematic Investigation on Interactions for HIV Drug Resistance and Cross-Resistance among Protease Inhibitors

Cancer mutations converge on a collection of protein assemblies to predict resistance to replication stress

Prediction of Potential Drug Targets Based on Simple Sequence Properties